[{"Assets_0_Q2_USD":265413000.0,"CommonStockSharesOutstanding_0_Q2_shares":14584000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":14063000.0,"NetIncomeLoss_1_Q2_USD":10092000.0,"NetIncomeLoss_2_Q2_USD":3405000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":14915000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":15045000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":14652000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":14666000.0,"StockholdersEquity_0_Q2_USD":246603000.0,"EarningsPerShareBasic_1_Q2_USD":0.69,"EarningsPerShareBasic_2_Q2_USD":0.23,"EarningsPerShareDiluted_1_Q2_USD":0.68,"EarningsPerShareDiluted_2_Q2_USD":0.23,"Ticker":"ANIK","CIK":"898437","name":"ANIKA THERAPEUTICS, INC.","OfficialName":"Anika Therapeutics Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"337949354.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20180731"}]